Søgeresultater - César Serrano
- Showing 1 - 20 results of 24
- Go to Next Page
-
1
-
2
-
3
-
4
Soft Tissue and Uterine Leiomyosarcoma af Suzanne George, César Serrano, Martee L. Hensley, Isabelle Ray‐Coquard
Udgivet 2017Revisão -
5
-
6
Cost Evaluation Analysis of Genetic Testing and Tailored Adjuvant Imatinib in Patients With Resected High-Risk GI Stromal Tumors: The Brazilian Perspective af Bruna Bianca Lopes David, Pedro Nazareth Aguiar, Matheus Costa e Silva, Rodrigo Dienstmann, Carlos Gil Ferreira, César Serrano
Udgivet 2023Artigo -
7
Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma af Suzanne George, Constance M. Barysauskas, César Serrano, Titilope Oduyebo, Jose Alejandro Rauh‐Hain, Marcela G. del Carmen, George D. Demetri, Michael G. Muto
Udgivet 2014Artigo -
8
-
9
The multifaceted landscape behind imatinib resistance in gastrointestinal stromal tumors (GISTs): A lesson from ripretinib af Aldo Di Vito, Gloria Ravegnini, Francesca Gorini, Trond Aasen, César Serrano, Eva Benuzzi, Emma Coschina, Sarah Monesmith, Fabiana Morroni, Sabrina Angelini, Patrizia Hrelia
Udgivet 2023Revisão -
10
RAS/MAPK pathway hyperactivation determines poor prognosis in undifferentiated pleomorphic sarcomas af César Serrano, Cleofé Romagosa, Javier Hernández‐Losa, S. Simonetti, Claudia Valverde, Teresa Moliné, Rosa Somoza, Manuel Llusà, Roberto Vélez, R. Vergés, Rosa Domínguez, Joan Carles, Santiago Ramón y Cajal
Udgivet 2015Artigo -
11
<i>KRAS</i> and <i>KIT</i> Gatekeeper Mutations Confer Polyclonal Primary Imatinib Resistance in GI Stromal Tumors: Relevance of Concomitant Phosphatidylinositol 3-Kinase/AKT Dysre... af César Serrano, Yuexiang Wang, Adrián Mariño‐Enríquez, Jen‐Chieh Lee, Gloria Ravegnini, Jeffrey A. Morgan, Monica M. Bertagnolli, Carol Beadling, George D. Demetri, Christopher L. Corless, Michael C. Heinrich, Jonathan A. Fletcher
Udgivet 2014Artigo -
12
2023 GEIS Guidelines for gastrointestinal stromal tumors af César Serrano, Javier Martín‐Broto, José Manuel Asencio, José Antonio López‐Guerrero, Jordi Rubió‐Casadevall, Sílvia Bagué, Xavier García del Muro, J. Fernández-Hernández, L. Herrero, Antonio López‐Pousa, Andrés Poveda, Virginia Martínez-Marín
Udgivet 2023Revisão -
13
Phase I Study of Rapid Alternation of Sunitinib and Regorafenib for the Treatment of Tyrosine Kinase Inhibitor Refractory Gastrointestinal Stromal Tumors af César Serrano, Alessandro Leal, Yanan Kuang, Jeffrey A. Morgan, Constance M. Barysauskas, Jillian Phallen, Olivia Triplett, Adrián Mariño‐Enríquez, Andrew J. Wagner, George D. Demetri, Victor E. Velculescu, Cloud P. Paweletz, Jonathan A. Fletcher, Suzanne George
Udgivet 2019Artigo -
14
Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial af Jean‐Yves Blay, César Serrano, Michael C. Heinrich, John Zalcberg, Sebastian Bauer, Hans Gelderblom, Patrick Schöffski, Robin L. Jones, Steven Attia, Gina Z. D’Amato, Ping Chi, Peter Reichardt, Julie Meade, Kelvin Shi, Rodrigo Ruiz‐Soto, Suzanne George, Margaret von Mehren
Udgivet 2020Artigo -
15
Clinical Activity of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumor Harboring Heterogeneous <i>KIT/PDGFRA</i> Mutations in the Phase III INVICTUS Study af Sebastian Bauer, Michael C. Heinrich, Suzanne George, John Zalcberg, César Serrano, Hans Gelderblom, Robin L. Jones, Steven Attia, Gina Z. D’Amato, Ping Chi, Peter Reichardt, Julie Meade, Ying Su, Rodrigo Ruiz‐Soto, Jean‐Yves Blay, Margaret von Mehren, Patrick Schöffski
Udgivet 2021Artigo -
16
Avapritinib in unresectable or metastatic PDGFRA D842V-mutant gastrointestinal stromal tumours: Long-term efficacy and safety data from the NAVIGATOR phase I trial af Robin L. Jones, César Serrano, Margaret von Mehren, Suzanne George, Michael C. Heinrich, Yoon‐Koo Kang, Patrick Schöffski, Philippe A. Cassier, Olivier Mir, Sant P. Chawla, Ferry A.L.M. Eskens, Piotr Rutkowski, William D. Tap, Teresa Zhou, Maria Roche, Sebastian Bauer
Udgivet 2021Artigo -
17
Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritin... af César Serrano, Sebastian Bauer, David Gómez-Peregrina, Yoon‐Koo Kang, Robin L. Jones, Piotr Rutkowski, Olivier Mir, Michael C. Heinrich, William D. Tap, Kate J. Newberry, A. Grassian, Hang Shi, Steve Bialick, Patrick Schöffski, Maria A. Pantaleo, Margaret von Mehren, Jonathan C. Trent, Suzanne George
Udgivet 2023Artigo -
18
Ponatinib Inhibits Polyclonal Drug-Resistant KIT Oncoproteins and Shows Therapeutic Potential in Heavily Pretreated Gastrointestinal Stromal Tumor (GIST) Patients af Andrew P. Garner, Joseph M. Gozgit, Rana Anjum, Sadanand Vodala, Alexa B. Schrock, Tianjun Zhou, César Serrano, Grant Eilers, Mei‐Jun Zhu, Julia Ketzer, Scott Wardwell, Yaoyu Ning, Youngchul Song, Anna Kohlmann, Frank Wang, Tim Clackson, Michael C. Heinrich, Jonathan A. Fletcher, Sebastian Bauer, Victor M. Rivera
Udgivet 2014Artigo -
19
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours af César Serrano, Adrián Mariño‐Enríquez, Derrick L. Tao, Julia Ketzer, Grant Eilers, Mei‐Jun Zhu, Channing Yu, Aristotle M. Mannan, Brian P. Rubin, George D. Demetri, Chandrajit P. Raut, Ajia Presnell, Arin McKinley, Michael C. Heinrich, Jeffrey T. Czaplinski, Ewa Sicińska, Sebastian Bauer, Suzanne George, Jonathan A. Fletcher
Udgivet 2019Artigo -
20
Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors af César Serrano, Ana Vivancos, Antonio López‐Pousa, Judit Matito, Francesco M. Mancuso, Claudia Valverde, Sergi Quiroga, Stefania Landolfi, Sandra Castro, Cristina Dopazo, Ana Sebio, Anna Virgili, María M. Menso, Javier Martín‐Broto, Miriam Sansó, Alfonso García‐Valverde, Jordi Rosell, Jonathan A. Fletcher, Suzanne George, Joan Carles, Joaquı́n Arribas
Udgivet 2020Artigo
Søgeredskaber:
Relaterede emner
Medicine
Internal medicine
Stromal cell
Cancer
GiST
Oncology
Biology
Imatinib
Myeloid leukemia
Cancer research
Colorectal cancer
PDGFRA
Sunitinib
Stromal tumor
Imatinib mesylate
Regorafenib
Pathology
Tyrosine-kinase inhibitor
Genetics
Sarcoma
Gene
Bioinformatics
Clinical trial
Gastroenterology
Receptor
Soft tissue sarcoma
Targeted therapy
Adverse effect
Biomarker
Clinical endpoint